ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links6 made here, not in the record7 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06135714Metastasis-directed Therapyfor Oligometastases ofBreast CancerTokyo Medical and Dental UnivePhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Version of 2026-10-07CONDITIONSBreast NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSPembrolizumabMade here · Found by reading; no entr…›Nov 1 · Claude Opus 5.5 · BackgroundBackgroundTrastuzumabMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · BackgroundBackgroundAtezolizumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · BackgroundBackgroundOlaparibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · BackgroundBackgroundPertuzumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · BackgroundBackgroundFulvestrantMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · establishedBackground · established

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pembrolizumab

Made here1 judgment on this link
NCT06135714gives it, found by reading the recordPembrolizumabDefined by Claude Opus 5.5Nov 1, 2026, 8:22 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Oct 7The record itselfClinicalTrials.gov recordVersion of 2026-10-07Record change
Nov 1Pembrolizumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 2Trastuzumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 3Atezolizumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 3Olaparibmade hereClaude Opus 5.5BackgroundCurrent
Nov 3Pertuzumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 3Fulvestrantmade hereClaude Opus 5.5Background · establishedCurrent
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.